Establishment and Clinical Application of a RPA-LFS Assay for Detection of Capsulated and Non-Capsulated Haemophilus influenzae
A recombinase polymerase amplification-lateral flow strip assay was established for detection of the outer membrane protein P6 ( ) and the capsule encoding gene of and the detection limit, sensitivity, and specificity were determined. Specific primers and probes were designed based on the published...
Gespeichert in:
Veröffentlicht in: | Frontiers in cellular and infection microbiology 2022-04, Vol.12, p.878813-878813 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A recombinase polymerase amplification-lateral flow strip assay was established for detection of the outer membrane protein P6 (
) and the capsule encoding gene
of
and the detection limit, sensitivity, and specificity were determined. Specific primers and probes were designed based on the published nucleotide sequences of
and
. The minimum detection limit was determined with standard strains and the practical applicability of the RPA-LFS assay was assessed by detection of 209 clinical samples. The results confirmed that the RPA-LFS assay was both specific and sensitive for the detection of capsulated and non-capsulated
with a detection limit of 1 CFU/µL. The detection rate of the 209 clinical samples was 97.1%, while the detection rate of capsulated
was 63.2%. The detection results were consistent with the traditional culture method and dual polymerase chain reaction (PCR), confirming the applicability of the RPA-LFS assay. |
---|---|
ISSN: | 2235-2988 2235-2988 |
DOI: | 10.3389/fcimb.2022.878813 |